demonstrated that physiological ATP1A1 expression in HCC cells exerts antitumor effects via epigenetic regulation and enhancement of autophagy, suggesting that ATP1A1 dysregulation may contribute to metabolic reprogramming and tumor progression. The gene discussed is ATP1A1; the disease is hepatocellular carcinoma.